meglumine antimoniate has been researched along with pentamidine in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (8.33) | 18.7374 |
1990's | 9 (37.50) | 18.2507 |
2000's | 8 (33.33) | 29.6817 |
2010's | 1 (4.17) | 24.3611 |
2020's | 4 (16.67) | 2.80 |
Authors | Studies |
---|---|
Bigaignon, G; Cornu, G; Mattot, M; Ninane, J; Vermylen, C | 1 |
Croft, SL; Frommel, D; Gebre-Hiwot, A; Tadesse, G | 1 |
Castillo, R; Hernández-Quero, J; Jiménez, E; Medrano, FJ; Pineda, JA; Reyes, MJ; Rivero, A; Sánchez-Quijano, A; Velez, ID; Viciana, P | 1 |
Casillas, A; Costa, JR; de Dios Garcia, J; del Mar Sanz, M; Guijarro, C; Martinez, R; Rubio, R | 1 |
Anciaux, ML; Bourée, P; Taugourdeau, P | 1 |
Tsetentis, Y | 1 |
Buffet, P; Caumes, E; Gentilini, M | 1 |
Alcácer, F; Aznar, J; Colomina, J; Ferriols, F; Magraner, J; Orovitg, F; Rodilla, F | 1 |
Ozsoylu, S | 1 |
Dumon, H; Gambarelli, F; Garnier, JM; Kaplanski, S; Piarroux, R; Unal, D | 1 |
Astier, A; Bories, C; Deniau, M; Durand, R; Fusai, T; Houin, R; Paul, M; Rivollet, D | 1 |
Holzmuller, P; Lemesre, JL; Sereno, D | 1 |
Banzet, S | 1 |
Delgado, G; Moreno, A; Patarroyo, ME; Puentes, F | 1 |
Andersen, EM; Berman, JD; Colina, O; Cruz-Saldarriaga, M; Echevarria, J; Llanos-Cuentas, A; Luz-Cjuno, M; Miranda-Verastegui, C | 1 |
Aguado, JM; Costa, JR; López-Medrano, F; Rodriguez-Peralto, JL | 1 |
Amato Neto, V; Amato, VS; Graf, ME; Nicodemo, AC; Siqueira, AM; Tuon, FF | 1 |
Barnabas, GA; Morrone, A; Padovese, V; Terranova, M; Toma, L | 1 |
García-Lázaro, M; Natera, C; Rivero, A; Villar, C | 1 |
Cesetti, MV; de Morais, OO; Gomes, CM; Mendes, MS; Roselino, AM; Sampaio, RN | 1 |
Cunha, MAD; Luz, KG; Shaw, JJ; Sousa, ASV; Vechi, HT | 1 |
da Silva, JHM; de Barros, NB; de Figueiredo Nicolete, LD; Dos Santos Ferreira, A; Macedo, SRA; Nicolete, R; Valentim-Silva, JR | 1 |
Bartoloni, A; Basile, G; Bresci, S; Cristofaro, G; Di Muccio, T; Gaiera, G; Gallo, O; Gradoni, L; Gramiccia, M; Locatello, LG; Maggiore, G; Novelli, A; Piccica, M; Vellere, I; Zammarchi, L | 1 |
Alvarado, MT; Cantillo-Barraza, O; Correa-Cárdenas, CA; Cruz, C; Duque, MC; Méndez, C; Patino, LH; Pérez, J; Ramírez, JD; Rodríguez, O; Romero, Y | 1 |
2 review(s) available for meglumine antimoniate and pentamidine
Article | Year |
---|---|
[Treatment of localized cutaneous leishmaniasis].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1994 |
Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Developing Countries; Endemic Diseases; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Pentamidine | 2008 |
1 trial(s) available for meglumine antimoniate and pentamidine
Article | Year |
---|---|
Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
Topics: Adult; Animals; Antiprotozoal Agents; Female; Humans; Infusions, Intravenous; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Peru; Treatment Outcome | 2005 |
21 other study(ies) available for meglumine antimoniate and pentamidine
Article | Year |
---|---|
Visceral and cutaneous leishmaniasis in an European paediatric population.
Topics: Animals; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1992 |
An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Evaluation, Preclinical; Humans; Leishmania; Leishmania donovani; Leukemia, Monocytic, Acute; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Pentamidine; Species Specificity; Tumor Cells, Cultured | 1992 |
Visceral leishmaniasis in HIV-1-infected individuals: a common opportunistic infection in Spain?
Topics: Adult; AIDS-Related Opportunistic Infections; Allopurinol; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; Female; HIV-1; Hospitals, University; Humans; Leishmaniasis, Visceral; Leukocyte Count; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Retrospective Studies; Spain; Treatment Outcome | 1992 |
Visceral leishmaniasis in HIV-infected patients.
Topics: Adult; Amphotericin B; Antiprotozoal Agents; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Spain; Treatment Outcome | 1991 |
[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
Topics: Adolescent; Adult; Antimony; Antimony Sodium Gluconate; Child; Child, Preschool; Female; Gluconates; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Splenectomy | 1985 |
[Treatment of visceral leishmaniasis].
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance, Microbial; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Mice; Organometallic Compounds; Pentamidine | 1985 |
Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Substance Abuse, Intravenous | 1994 |
Treatment of kala azar.
Topics: Antimony; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1996 |
[Resistance of Leishmania infantum to Glucantime: risk factors and therapeutic management].
Topics: Animals; Antiprotozoal Agents; Drug Resistance; Female; Humans; Immunity, Cellular; Infant; Interferon-gamma; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Recurrence | 1996 |
Action of pentamidine-bound nanoparticles against Leishmania on an in vivo model.
Topics: Animals; Antimony; Antiprotozoal Agents; Colloids; Disease Models, Animal; Drug Carriers; Female; Leishmania major; Leishmaniasis, Visceral; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microspheres; Organometallic Compounds; Pentamidine; Polymethacrylic Acids; Random Allocation | 1994 |
Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum.
Topics: Amphotericin B; Animals; Antimony Potassium Tartrate; Antiprotozoal Agents; Cell Line; Drug Resistance; Humans; Leishmania infantum; Meglumine; Meglumine Antimoniate; Mutation; Organometallic Compounds; Pentamidine | 2000 |
[Epidemics of cutaneous leishmaniasis in military personnel working in French Guiana].
Topics: Antiprotozoal Agents; Bedding and Linens; Clothing; French Guiana; Humans; Insect Repellents; Insecticides; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds; Pentamidine; Recurrence; Skin; Trees | 2000 |
Flow cytometry, a useful tool for detecting the lethal effect of pentamidine on Leishmania viannia complex promastigote forms.
Topics: Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Flow Cytometry; Humans; Leishmania guyanensis; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Propidium; Sensitivity and Specificity | 2001 |
An HIV-positive man with tattoo induration.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immunohistochemistry; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Risk Assessment; Tattooing | 2007 |
Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns.
Topics: Adolescent; Adult; Antiprotozoal Agents; Child; Child, Preschool; Ethiopia; Female; HIV Infections; HIV-1; Humans; Infant; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Socioeconomic Factors; Young Adult | 2009 |
[Raised tattoos in a human-immunodeficiency-virus-infected patient].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; CD4-Positive T-Lymphocytes; Hepatitis C, Chronic; Histiocytes; Humans; Lamivudine; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Lopinavir; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Patient Compliance; Pentamidine; Pyrimidinones; Recurrence; Ritonavir; Tattooing; Zidovudine | 2009 |
The influence of treatment on the development of leishmaniasis recidiva cutis: a 17-year case-control study in Midwestern Brazil.
Topics: Adolescent; Adult; Amphotericin B; Brazil; Case-Control Studies; Female; Humans; Incidence; Leishmaniasis, Cutaneous; Longitudinal Studies; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Trypanocidal Agents; Young Adult | 2015 |
Case Report: Combination Therapy with Liposomal Amphotericin B, N-Methyl Meglumine Antimoniate, and Pentamidine Isethionate for Disseminated Visceral Leishmaniasis in a Splenectomized Adult Patient.
Topics: Amphotericin B; Antiprotozoal Agents; Bone Marrow; Drug Therapy, Combination; Humans; Immunocompromised Host; Intestinal Mucosa; Leishmaniasis, Visceral; Lymph Nodes; Male; Meglumine Antimoniate; Middle Aged; Pentamidine; Splenectomy | 2020 |
Antileishmanial drugs activate inflammatory signaling pathways via toll-like receptors (docking approach) from Leishmania amazonensis-infected macrophages.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Inflammation; Leishmania; Leishmaniasis; Macrophages; Meglumine Antimoniate; Mice; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; Pentamidine; Signal Transduction; Toll-Like Receptors; Transcription Factor RelA | 2020 |
Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate.
Topics: Administration, Intravenous; Aged; Amphotericin B; Antiprotozoal Agents; Argentina; Azoles; Drug Therapy, Combination; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Pentamidine; Recurrence | 2020 |
Distribution, treatment outcome and genetic diversity of Leishmania species in military personnel from Colombia with cutaneous leishmaniasis.
Topics: Antiprotozoal Agents; Colombia; DNA, Protozoan; Genetic Variation; Haplotypes; HSP70 Heat-Shock Proteins; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Military Personnel; Pentamidine; Phylogeny; Polymerase Chain Reaction; Treatment Outcome; Young Adult | 2020 |